- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-octamer
- Ligands
- 16 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)(Covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Covalent)
ATP.3: 14 residues within 4Å:- Chain A: S.164, S.165, R.166, T.185, D.189, L.190, V.191, K.211, G.212, K.213, P.215, R.229
- Chain F: R.229
- Ligands: GTP.1
11 PLIP interactions:1 interactions with chain F, 10 interactions with chain A- Salt bridges: F:R.229, A:R.166, A:R.166, A:R.166
- Hydrogen bonds: A:S.164, A:S.165, A:R.166, A:R.166, A:V.191, A:K.213, A:R.229
ATP.8: 14 residues within 4Å:- Chain B: S.164, S.165, R.166, T.185, D.189, L.190, V.191, K.211, G.212, K.213, P.215, R.229
- Chain E: R.229
- Ligands: GTP.6
11 PLIP interactions:1 interactions with chain E, 10 interactions with chain B- Salt bridges: E:R.229, B:R.166, B:R.166, B:R.166
- Hydrogen bonds: B:S.164, B:S.165, B:R.166, B:R.166, B:V.191, B:K.213, B:R.229
ATP.13: 14 residues within 4Å:- Chain C: S.164, S.165, R.166, T.185, D.189, L.190, V.191, K.211, G.212, K.213, P.215, R.229
- Chain H: R.229
- Ligands: GTP.11
11 PLIP interactions:10 interactions with chain C, 1 interactions with chain H- Hydrogen bonds: C:S.164, C:S.165, C:R.166, C:R.166, C:V.191, C:K.213, C:R.229
- Salt bridges: C:R.166, C:R.166, C:R.166, H:R.229
ATP.18: 14 residues within 4Å:- Chain D: S.164, S.165, R.166, T.185, D.189, L.190, V.191, K.211, G.212, K.213, P.215, R.229
- Chain G: R.229
- Ligands: GTP.16
11 PLIP interactions:10 interactions with chain D, 1 interactions with chain G- Hydrogen bonds: D:S.164, D:S.165, D:R.166, D:R.166, D:V.191, D:K.213, D:R.229
- Salt bridges: D:R.166, D:R.166, D:R.166, G:R.229
ATP.23: 14 residues within 4Å:- Chain B: R.229
- Chain E: S.164, S.165, R.166, T.185, D.189, L.190, V.191, K.211, G.212, K.213, P.215, R.229
- Ligands: GTP.21
11 PLIP interactions:10 interactions with chain E, 1 interactions with chain B- Hydrogen bonds: E:S.164, E:S.165, E:R.166, E:R.166, E:V.191, E:K.213, E:R.229
- Salt bridges: E:R.166, E:R.166, E:R.166, B:R.229
ATP.28: 14 residues within 4Å:- Chain A: R.229
- Chain F: S.164, S.165, R.166, T.185, D.189, L.190, V.191, K.211, G.212, K.213, P.215, R.229
- Ligands: GTP.26
11 PLIP interactions:1 interactions with chain A, 10 interactions with chain F- Salt bridges: A:R.229, F:R.166, F:R.166, F:R.166
- Hydrogen bonds: F:S.164, F:S.165, F:R.166, F:R.166, F:V.191, F:K.213, F:R.229
ATP.33: 14 residues within 4Å:- Chain D: R.229
- Chain G: S.164, S.165, R.166, T.185, D.189, L.190, V.191, K.211, G.212, K.213, P.215, R.229
- Ligands: GTP.31
11 PLIP interactions:10 interactions with chain G, 1 interactions with chain D- Hydrogen bonds: G:S.164, G:S.165, G:R.166, G:R.166, G:V.191, G:K.213, G:R.229
- Salt bridges: G:R.166, G:R.166, G:R.166, D:R.229
ATP.38: 14 residues within 4Å:- Chain C: R.229
- Chain H: S.164, S.165, R.166, T.185, D.189, L.190, V.191, K.211, G.212, K.213, P.215, R.229
- Ligands: GTP.36
11 PLIP interactions:10 interactions with chain H, 1 interactions with chain C- Hydrogen bonds: H:S.164, H:S.165, H:R.166, H:R.166, H:V.191, H:K.213, H:R.229
- Salt bridges: H:R.166, H:R.166, H:R.166, C:R.229
- 8 x IMP: INOSINIC ACID(Non-covalent)
IMP.4: 21 residues within 4Å:- Chain A: S.73, M.75, R.327, S.334, I.335, C.336, D.369, G.370, G.371, I.372, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.5
13 PLIP interactions:13 interactions with chain A- Hydrogen bonds: A:S.73, A:R.327, A:S.334, A:G.370, A:G.371, A:I.372, A:I.372, A:M.390, A:G.392, A:S.393, A:S.393, A:G.420, A:Q.446
IMP.9: 21 residues within 4Å:- Chain B: S.73, M.75, R.327, S.334, I.335, C.336, D.369, G.370, G.371, I.372, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.10
13 PLIP interactions:13 interactions with chain B- Hydrogen bonds: B:S.73, B:R.327, B:S.334, B:G.370, B:G.371, B:I.372, B:I.372, B:M.390, B:G.392, B:S.393, B:S.393, B:G.420, B:Q.446
IMP.14: 21 residues within 4Å:- Chain C: S.73, M.75, R.327, S.334, I.335, C.336, D.369, G.370, G.371, I.372, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.15
13 PLIP interactions:13 interactions with chain C- Hydrogen bonds: C:S.73, C:R.327, C:S.334, C:G.370, C:G.371, C:I.372, C:I.372, C:M.390, C:G.392, C:S.393, C:S.393, C:G.420, C:Q.446
IMP.19: 21 residues within 4Å:- Chain D: S.73, M.75, R.327, S.334, I.335, C.336, D.369, G.370, G.371, I.372, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.20
13 PLIP interactions:13 interactions with chain D- Hydrogen bonds: D:S.73, D:R.327, D:S.334, D:G.370, D:G.371, D:I.372, D:I.372, D:M.390, D:G.392, D:S.393, D:S.393, D:G.420, D:Q.446
IMP.24: 21 residues within 4Å:- Chain E: S.73, M.75, R.327, S.334, I.335, C.336, D.369, G.370, G.371, I.372, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.25
15 PLIP interactions:15 interactions with chain E- Hydrogen bonds: E:S.73, E:R.327, E:S.334, E:D.369, E:G.370, E:G.371, E:I.372, E:I.372, E:M.390, E:G.392, E:S.393, E:S.393, E:Y.416, E:G.420, E:Q.446
IMP.29: 21 residues within 4Å:- Chain F: S.73, M.75, R.327, S.334, I.335, C.336, D.369, G.370, G.371, I.372, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.30
15 PLIP interactions:15 interactions with chain F- Hydrogen bonds: F:S.73, F:R.327, F:S.334, F:D.369, F:G.370, F:G.371, F:I.372, F:I.372, F:M.390, F:G.392, F:S.393, F:S.393, F:Y.416, F:G.420, F:Q.446
IMP.34: 21 residues within 4Å:- Chain G: S.73, M.75, R.327, S.334, I.335, C.336, D.369, G.370, G.371, I.372, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.35
15 PLIP interactions:15 interactions with chain G- Hydrogen bonds: G:S.73, G:R.327, G:S.334, G:D.369, G:G.370, G:G.371, G:I.372, G:I.372, G:M.390, G:G.392, G:S.393, G:S.393, G:Y.416, G:G.420, G:Q.446
IMP.39: 21 residues within 4Å:- Chain H: S.73, M.75, R.327, S.334, I.335, C.336, D.369, G.370, G.371, I.372, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.40
15 PLIP interactions:15 interactions with chain H- Hydrogen bonds: H:S.73, H:R.327, H:S.334, H:D.369, H:G.370, H:G.371, H:I.372, H:I.372, H:M.390, H:G.392, H:S.393, H:S.393, H:Y.416, H:G.420, H:Q.446
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.5: 17 residues within 4Å:- Chain A: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, R.327, C.336, D.369, M.419, G.420, Q.446
- Chain D: I.47, Q.474
- Ligands: IMP.4
12 PLIP interactions:1 interactions with chain D, 11 interactions with chain A- Hydrogen bonds: D:Q.474, A:T.257, A:E.259, A:D.279, A:S.281, A:N.308, A:D.369
- Salt bridges: A:H.258
- pi-Stacking: A:H.258, A:H.258, A:F.287, A:F.287
NAD.10: 17 residues within 4Å:- Chain A: I.47, Q.474
- Chain B: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, R.327, C.336, D.369, M.419, G.420, Q.446
- Ligands: IMP.9
12 PLIP interactions:11 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:T.257, B:E.259, B:D.279, B:S.281, B:N.308, B:D.369, A:Q.474
- Salt bridges: B:H.258
- pi-Stacking: B:H.258, B:H.258, B:F.287, B:F.287
NAD.15: 17 residues within 4Å:- Chain B: I.47, Q.474
- Chain C: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, R.327, C.336, D.369, M.419, G.420, Q.446
- Ligands: IMP.14
12 PLIP interactions:11 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:T.257, C:E.259, C:D.279, C:S.281, C:N.308, C:D.369, B:Q.474
- Salt bridges: C:H.258
- pi-Stacking: C:H.258, C:H.258, C:F.287, C:F.287
NAD.20: 17 residues within 4Å:- Chain C: I.47, Q.474
- Chain D: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, R.327, C.336, D.369, M.419, G.420, Q.446
- Ligands: IMP.19
12 PLIP interactions:11 interactions with chain D, 1 interactions with chain C- Hydrogen bonds: D:T.257, D:E.259, D:D.279, D:S.281, D:N.308, D:D.369, C:Q.474
- Salt bridges: D:H.258
- pi-Stacking: D:H.258, D:H.258, D:F.287, D:F.287
NAD.25: 17 residues within 4Å:- Chain E: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, R.327, C.336, D.369, M.419, G.420, Q.446
- Chain H: I.47, Q.474
- Ligands: IMP.24
13 PLIP interactions:11 interactions with chain E, 2 interactions with chain H- Hydrogen bonds: E:T.257, E:E.259, E:D.279, E:S.281, E:N.308, E:D.369, H:T.50, H:Q.474
- Salt bridges: E:H.258
- pi-Stacking: E:H.258, E:H.258, E:F.287, E:F.287
NAD.30: 17 residues within 4Å:- Chain E: I.47, Q.474
- Chain F: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, R.327, C.336, D.369, M.419, G.420, Q.446
- Ligands: IMP.29
12 PLIP interactions:1 interactions with chain E, 11 interactions with chain F- Hydrogen bonds: E:Q.474, F:T.257, F:E.259, F:D.279, F:S.281, F:N.308, F:D.369
- Salt bridges: F:H.258
- pi-Stacking: F:H.258, F:H.258, F:F.287, F:F.287
NAD.35: 17 residues within 4Å:- Chain F: I.47, Q.474
- Chain G: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, R.327, C.336, D.369, M.419, G.420, Q.446
- Ligands: IMP.34
13 PLIP interactions:2 interactions with chain F, 11 interactions with chain G- Hydrogen bonds: F:T.50, F:Q.474, G:T.257, G:E.259, G:D.279, G:S.281, G:N.308, G:D.369
- Salt bridges: G:H.258
- pi-Stacking: G:H.258, G:H.258, G:F.287, G:F.287
NAD.40: 17 residues within 4Å:- Chain G: I.47, Q.474
- Chain H: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, R.327, C.336, D.369, M.419, G.420, Q.446
- Ligands: IMP.39
12 PLIP interactions:11 interactions with chain H, 1 interactions with chain G- Hydrogen bonds: H:T.257, H:E.259, H:D.279, H:S.281, H:N.308, H:D.369, G:Q.474
- Salt bridges: H:H.258
- pi-Stacking: H:H.258, H:H.258, H:F.287, H:F.287
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johnson, M.C. et al., Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife (2020)
- Release Date
- 2020-03-25
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-octamer
- Ligands
- 16 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)(Covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Covalent)
- 8 x IMP: INOSINIC ACID(Non-covalent)
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johnson, M.C. et al., Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife (2020)
- Release Date
- 2020-03-25
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H